FILTERED RESULTS
FILTERS
•
·
·
FILTERED RESULTS
Oil holds losses as Middle East supply recovers; set for monthly jump
UK economic output revised up to show stronger Q2 growth
Paramount Deal Delay Fuels Fear of Costly $52 Billion Debt
Erdogan Hands Turkey Investment Fund Cleanup to Vice President
Clearlake Wraps Up $1 Billion CFO Trade After Rejigging Deal
UK energy price cap forecast to rise to nearly £2,000 as Iran war drives up prices
France's September Inflation Rate Surpasses Expectations
French Inflation Quickens to Highest in More Than Two Years
India’s Opposition Leaders Unite as Election Chief Crisis Mounts
Australia stocks higher at close of trade; S&P/ASX 200 up 0.92%
Bond yields weigh on stocks - but this medical device name is up 19%
Hungary posts €480.9 million trade deficit in August
German import prices rise 8.3% in August, above forecasts
Japan PM Takaichi to vow nimble response to unexpected market moves, Nikkei says
Inflation Data and Economic Reports Shape Market Expectations
UK’s Strong First Half Boosted by Upwardly Revised GDP Estimate
Real Estate Stocks Are a Bold Bet on Monetary Policy Reversal
Asia stocks gain ahead of U.S. PCE inflation; regional data in focus
Six tech and healthcare picks up 18%–32% this month - the leader is up 34%
UK economy grew faster than first estimated in second quarter
China’s Biggest Stimulus Push Since 2024 Underwhelms Markets
Why is SoftBank Group stock surging today?
Taiwan stocks higher at close of trade; Taiwan Weighted up 1.12%
UK Q2 GDP growth revised up to 0.5% on stronger services, exports
Dollar set for big rise in September, mainly at euro’s expense
UK economy grew by 0.5% in Q2 2026, ONS says
U.S. Treasury Yields Fall on Dovish-Leaning Fed Speech
How Abu Dhabi's Crown Prince Is Trying to Bypass Hormuz
UK Final GDP Growth Revised Upward for Q2 2026
UK Economy Grew More Than Expected in Second Quarter
Goldman's Drayton: APAC Deals Boom May Last to '27
Germany Reports 1.0% Increase in August Import Prices
Germany's Retail Sales Increase by 1.3% in August, Below Expectations
UAE and Egypt renew $1.4bn currency swap agreement
How Abu Dhabi's Crown Price Is Trying to Bypass Hormuz (Video)
Top China Biopharma Stocks to Watch, According to Bernstein
UK business confidence hits 17-month low as Middle East tensions lift costs
FTSE 100 Live: UK Stocks Set for Rebound, Pound Reverses Decline
Bond markets regain composure after Treasuries surge overnight
China adds 55% tariff to Brazil beef as imports hit quota
Gold edges lower as Treasury yields offset softer oil, Fed hike concerns linger
Australia’s Metrics freezes some fund redemptions in sign of private credit market stress
UK PM Burnham says Britain should consider rejoining European Union
China Repo Push Advances as Legal Issues, Low Yields Drag
Capitec Profit, Dividend Hit Record as Clients Top 26.6 Million
Midterms and the market
DeepSeek partners with Huawei on chip programming tools amid pivot from Nvidia
Singapore electricity tariff to fall 10.4% on lower energy costs
Bonds set for bruising September but stocks little fazed
China Extends Military Reach With New Air Support Base in Laos
Trump weighs diesel export ban to contain U.S. fuel prices, FT reports
Apple iPhone 18 Pro sales rise 12% in China launch week - Counterpoint
Bernstein's Liang on China's Biotech Stock Rally
Bassiri Tabrizi: US Iran Moving Further Apart in Talks (Video)
Vale Mulls Raising Over $500 Million in Debut Panda Bond Sale
Nikkei 225 tests resistance at 66,960 with weak ADX: Live levels
SK Hynix consolidates in Ichimoku cloud at ₩1.8M: Live
Key FX Option Expiries to Influence Currency Movements on September 30
China’s Biggest Stimulus Push Since 2024 Falls Flat With Markets
Stocks Rebound, Bonds Steady Before Key US Data: Markets Wrap
EU decarbonisation incentives do not add up, says US chemicals giant
Bank runs are almost always justified
Why is SUMCO stock surging today?
China factory activity grows at fastest pace in 5 months in Sept: RatingDog PMI
Qatar urges diplomacy as US and Iran both claim Hormuz control
Political Fix from the Labour Party conference: Hope again?
FirstFT: US holds crunch talks over diesel export ban
Why is Taiyo Yuden stock rising today?
Japan’s TDK, Taiyo Yuden shares rise on AI electronics partnership
Eli Lilly Reports Significant Weight Loss Results for Retatrutide in Phase 3 Trial
Eli Lilly and Company has announced that its investigational drug, Retatrutide, has demonstrated an average weight loss of 20.8% over 80 weeks in a Phase 3 clinical trial. This promising outcome highlights the potential of Retatrutide as a treatment for obesity, which is a growing health concern globally.
In light of these results, Eli Lilly plans to submit a Biologics License Application for Retatrutide in the first quarter of 2027. The company aims to bring this innovative treatment to market, which could significantly impact the management of obesity and related health issues.
The Phase 3 trial results are part of Eli Lilly's ongoing commitment to addressing obesity through advanced therapeutic options. The company is headquartered in Indianapolis, Indiana, USA, and continues to focus on developing solutions that improve patient outcomes.
© 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.
Source: KLEA News